Milestone advances two-part study evaluating novel, locally administered gene therapy designed to increase anti-inflammatory IL-1Ra production in the knee joint -- ...

The Alliance for Clinical Trials in Oncology has launched a new clinical trial seeking to evaluate the feasibility of ...

When you’re preparing for a dental crown procedure in New York City, expect a meticulous process that begins with a thorough ...

AI may be making workers complacent. As more professions begin to rely on artificial intelligence technology, certain skills ...

- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Nirogacestat significantly improved progression-free survival and objective response rates in desmoid tumor patients compared ...

Objective Interstitial lung disease (ILD) represents the most common and severe organ manifestation observed in patients ...

Over the past few days, medtech's biggest names gathered in San Francisco for the Transcatheter Cardiovascular Therapies (TCT ...

This valuable study examined the roles of the posterior parietal cortex in rats performing an auditory change-detection decision task. It provided solid evidence for two subpopulations with opposing ...

Research and development expenses for the third quarter of 2025 were $52.4 million versus $37.1 million for the comparable quarter in 2024, reflecting an increase in overall clinical expenses ...

PRESSADVANTAGE – StephenTwomey.com has released a new educational resource titled “The Ultimate Glossary of Hedge Fund, Private Equity & Alternative Investment Terms (2025 Guide)”, offering accredited ...

Guard Therapeutics (publ) today announced top-line results from the company's Phase 2b POINTER study evaluating the investigational drug candidate RMC-035 as a kidney-protective therapy in patients un ...